ClinicalTrials.gg
RecruitingNCT07461194Updated Oct 14, 2026

Timing of Broccoli Sprout Intake to Improve Exercise Performance

An interventional study of Broccoli sprout drink (isothiocyanate-rich and Placebo drink in Physical Performance, Glucose and Glycogen Metabolism, sponsored by The Swedish School of Sport and Health Sciences. Recruiting at 1 site in Sweden. Open to participants aged 18 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-14.

Sponsored by The Swedish School of Sport and Health Sciences · Not applicable, Interventional, and Basic science

How we know

From the registry’s dates

  • Started Aug 2026; still recruiting 3 months later.
Updated Oct 14, 2026Now RecruitingFirst site in Sweden+3 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years to 50 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 193 studies in Motor Activity with a site in Sweden — 43 open to participants now, 57 under way, none of them phase 3. Motor Activity · Sweden.

Planned enrollment
128th of 160
30 · median 98
Started
2026
with 11 others
No phase
148 of 193
35 open now
Primary completion
2027-12
later than 41 of 56 live
Registered
187th of 193
by date

Among the 193 studies in Motor Activity with a site in Sweden, this one is the 128th largest by planned enrollment of the 160 interventional ones that give a count, is one of 12 that started in 2026, is one of 148 with no phase, reaches primary completion later than 41 of the 56 other live ones, and was the 187th registered.

Motor Activity

9,827 studies on the registry are indexed under Motor Activity; 1,911 are open to participants now.

Browse Motor Activity studies →

Open to participants now

43 of the 193 studies in Motor Activity with a site in Sweden are open now. Recruiting first, the newest first:

37 more — sign in →

All 43 open studies →

A study can be open while its sites in Sweden have not opened yet or have stopped. Only those recruiting at a site in Sweden →

Who these studies take

Of the 1,207 Motor Activity studies recruiting now, 524 (43%) set no upper age limit and 538 (45%) stop at 75 or younger; 180 take children under 18; 420 take healthy volunteers.

This study: 18 Years to 50 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 193 studies in Motor Activity with a site in Sweden, or all of them as a file.
02

Study summary

This study examines how the timing of intake of a broccoli sprout-based drink (a natural source of isothiocyanates, ITCs) affects physiological responses, recovery, and performance after a standardized endurance cycling session. Healthy, endurance-trained adults (18-64 years) will complete four laboratory visits at the Swedish School of Sport and Health Sciences (GIH): one screening/physiology test visit and three intervention visits in a randomized, double-blind, placebo-controlled cross-over design. On intervention visits, participants will ingest either an active broccoli sprout drink (50 g sprouts) or a placebo drink based on alfalfa sprouts (50 g sprouts) according to randomization. The drink will be consumed either approximately 16 hours before exercise (the evening before) or approximately 3 hours before exercise (the morning of the test), enabling comparison of timing in relation to a standardized \~2-hour cycling protocol (individualized intensity) followed by a 10 km cycling time trial. Outcomes include measures of performance, heart rate, perceived exertion and recovery, blood glucose and lactate, and metabolic responses. Venous blood samples are collected at multiple time points before and after exercise and during the subsequent laboratory recovery period, and muscle biopsies are obtained at defined time points to assess muscle metabolism and recovery-related markers. Participants return \~24 hours after exercise for follow-up sampling after an overnight fast, including a glucose tolerance test

Read the detailed description

This is a randomized, double-blind, placebo-controlled cross-over study conducted at the Swedish School of Sport and Health Sciences (GIH), Stockholm, designed to isolate the effect of timing of isothiocyanate (ITC) intake from broccoli sprouts on exercise responses, recovery, and cycling performance. Each participant completes four laboratory visits: one screening/physiology visit and three intervention visits. The screening visit includes a health check and an incremental cycle test to determine maximal oxygen uptake and to individualize exercise intensities for subsequent visits; oxygen uptake is assessed by indirect calorimetry, and capillary fingertip samples are used to measure blood lactate and glucose during the test. A venous blood sample is collected at the screening visit.

Intervention visits (three separate occasions) follow the same standardized test-day structure with different drink assignments according to randomization. The active drink consists of 50 g broccoli sprouts (ITC source) and the placebo drink consists of 50 g alfalfa sprouts. Drinks are administered to compare "subacute" intake (approximately 16 hours before exercise, the evening prior) versus "acute" intake (approximately 3 hours before exercise, the morning of the test day). The three intervention conditions are: (1) placebo at \~16 h plus placebo at \~3 h before the cycling protocol (control), (2) active at \~16 h plus placebo at \~3 h (subacute condition), and (3) placebo at \~16 h plus active at \~3 h (acute condition). Participants and investigators/test staff are blinded to drink identity at each visit.

On each intervention test day, participants arrive to the laboratory (approximately 08:30) and compliance with pre-visit instructions is checked. Baseline samples are collected, including a muscle biopsy from vastus lateralis, venous blood, and saliva. Participants then complete a standardized, strenuous cycling protocol on an ergometer with individualized intensity based on the screening test (approximately 80% of VO2max). An example structure is repeated intervals around lactate threshold (e.g., 8 × 5 min work with short recovery), with physiological monitoring throughout. Heart rate is recorded continuously (smartwatch), and capillary blood lactate and glucose are measured at predefined time points during exercise. Oxygen uptake/energy metabolism may be monitored during portions of the protocol using indirect calorimetry.

The exercise protocol includes a 10 km cycling performance test on the ergometer. In addition, approximately 4 hours after completion of the initial cycling bout (and following the relevant sampling time point), participants perform a second 10 km ergometer time trial in which they are instructed to perform as well as possible. Perceived exertion is recorded during exercise, and perceived recovery is assessed during the recovery period (e.g., Perceived Recovery Status Scale).

Biological sampling is extensive to characterize acute and post-exercise recovery processes. At each intervention visit, venous blood is collected at 10 time points: pre-exercise, immediately post-exercise, and then once per hour during the subsequent 8-hour laboratory recovery period (approximately 4 mL per draw; \~40 mL per intervention visit). Muscle biopsies from vastus lateralis are collected at four time points per intervention visit: pre-exercise, immediately post-exercise, approximately 4 hours post-exercise, and approximately 24 hours post-exercise (separate incision sites; predetermined/randomized leg). Saliva sampling is also performed (including at baseline and at the end of the \~8-hour laboratory recovery period). During the 0-8 hour recovery period in the laboratory, standardized meals are provided.

After approximately 8 hours in the laboratory, participants leave and return the next day (\~24 hours after exercise) for final sampling, including the last muscle biopsy. For the 24-hour visit, participants fast for at least 10 hours. A glucose tolerance test is performed at the 24-hour follow-up to assess post-exercise glucose regulation.

03

Conditions studied

  • Physical Performance
  • Glucose
  • Glycogen Metabolism
  • Lactate
  • Broccoli Sprout
  • Isothiocyanate

Browse trials for

Keywords

  • Broccoli Sprouts
  • Lactate
  • Exercise
  • Glycogen
  • Isothiocyanate
04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Healthy, endurance-trained adults aged 18-64 years.

Regular endurance training (e.g., cycling/running) and ability to complete a standardized 2-hour high-intensity cycling session on an ergometer.

Approved health declaration and screening assessment by study staff (including that ergometer testing can be performed safely).

Willing and able to follow the study protocol (diet/fasting instructions, standardized training before visits, attendance at all four laboratory visits).

No known allergy/ to ingredients in the broccoli sprout drink or placebo drink.

Exclusion criteria

Exclusion Criteria:

Does not meet inclusion criteria at screening (e.g., abnormal health declaration or medical findings making intense endurance exercise or muscle inappropriate).

Known allergy/ to ingredients in the intervention or placebo drink (broccoli/cruciferous vegetables or alfalfa) or other relevant food allergy.

Ongoing illness, fever, or infection at any test occasion, or other acute medical event judged to affect safety or data quality.

Ongoing treatment with medications/supplements judged to affect primary outcomes or increase risk (e.g., anti-inflammatory medication close to test days per study instructions).

Pregnancy (if women are included) or breastfeeding.

Inability to comply with the study protocol (e.g., failure to standardize diet/fasting, deviating training/alcohol intake despite instructions, or repeated missed visits).

Participant withdraws consent or investigator judges continued participation to pose risk.

-

Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Hypersensitivity

An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.

Biopsy and archival tissue

A biopsy takes a small piece of tissue to examine. “Archival tissue” is a sample already taken, for example at diagnosis, and kept by the hospital.

Whether a stored sample will do depends on when it was taken, how much there is and what the study needs. Ask whether the study accepts your stored sample or needs a new biopsy.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Double (Participant, Investigator)
Enrollment
30 participants (estimated)

Study arms

  • Placebo comparator
    placebo

    Participants ingest placebo drink prepared from alfalfa sprouts (50 g) \~16 hours before exercise (evening prior) and placebo drink (50 g) \~3 hours before exercise (test day morning). Exercise protocol and sampling are identical to other conditions.

    Dietary Supplement: Placebo drink

  • Experimental
    active, ~16 hours pre exercise

    Participants ingest broccoli sprout drink (isothiocyanate-rich; 50 g sprouts) \~16 hours before exercise and placebo alfalfa sprout drink (50 g) \~3 hours before exercise. Exercise protocol and sampling are identical to other conditions.

    Dietary Supplement: Broccoli sprout drink (isothiocyanate-rich

  • Experimental
    active, ~3 hours pre exercise

    Participants ingest placebo alfalfa sprout drink (50 g) \~16 hours before exercise and broccoli sprout drink (isothiocyanate-rich; 50 g sprouts) \~3 hours before exercise. Exercise protocol and sampling are identical to other conditions.

    Dietary Supplement: Broccoli sprout drink (isothiocyanate-rich

Interventions

  • Dietary supplementBroccoli sprout drink (isothiocyanate-rich

    Active intervention is a drink prepared from broccoli sprouts (50 g per dose) as a natural source of glucosinolates/isothiocyanates (ITCs). Participants ingest the drink either \~16 hours before the exercise session (evening prior) or \~3 hours before the exercise session (test day morning), depending on randomized condition. The study compares the timing of ITC intake versus placebo, with identical procedures across conditions.

  • Dietary supplementPlacebo drink

    The placebo intervention is a drink prepared from alfalfa sprouts (50g per dose) as a placebo. Participants ingest the drink at both \~16 hours before the exercise session (evening prior) and \~3 hours before the exercise session (test day morning). The study compares the timing of ITC intake versus placebo, with identical procedures across conditions.

06

What researchers measure

Primary outcomes

  1. Lactate

    blood lactate (mmol/L) at predefined time points during exercise; venous sampling schedule as per protocol.

    Time frame: During exercise and across the 0 to 8 hours recovery period (hourly venous samples), and at the follow-up, approximately 24 hours post-exercise.

  2. Glucose

    Blood glucose (mmol/L) at predefined time points during exercise; venous sampling schedule as per protocol.

    Time frame: During exercise and across the 0 to 8 hours recovery period (hourly venous samples), and at the follow-up, approximately 24 hours post-exercise.

  3. Glycogen

    Muscle glycogen content in the vastus lateralis obtained from biopsies at pre-exercise, immediately post-exercise, 8 hours post-exercise, and 24 hours post-exercise to quantify glycogen depletion during exercise and repletion during recovery

    Time frame: Before exercise, immediately post-exercise, 8 hours post-exercise, and 24 hours post-exercise

Secondary outcomes

  1. Physical performance

    Time to complete the approximately 10-kilometer cycling time trial on an ergometer

    Time frame: Twice per visit. First, immediately following the standardized cycling protocol, and second, 4 hours post-exercise during the same intervention visit.

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — De-identified individual participant data (IPD) underlying the primary and secondary outcomes (and associated data dictionary/codebook) will be made available to qualified researchers upon reasonable request after publication of the primary results. Data will be shared in a de-identified form in accordance with Swedish/EU data protection regulations and the approved ethics application. Requests will be reviewed by the study investigators; data sharing may require a data use agreement and proof of ethical approval where applicable

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Aug 2026 (actual). Primary completion is estimated for Dec 2027, 16 months after the start.

Of 5,176 non-industry interventional studies with no phase under Motor Activity, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 36. This study's planned 16 months is close to that.

Counting every sponsor, half of 5,236 studies reached it within 17 months; a quarter within 7 and three quarters within 36.

Start moved once since we started tracking on Sep 25, 2026: Mar 2026 → Aug 2026, on Oct 14, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Feb 25, 2026
First posted
Mar 10, 2026
StartActual
Aug 15, 2026was Mar 2026
Primary completionEst.
Dec 31, 2027
CompletionEst.
Sep 1, 2028
Last update
Oct 14, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Oct 14, 2026
Sites
1 site added — first site in Sweden
Show site
  • Swedish School of Sport and Health Sciences · Stockholm, Sweden
Oct 14, 2026
Start date
Mar 31, 2026→Aug 15, 2026 (actual)
Oct 14, 2026
Primary completion
Dec 15, 2027→Dec 31, 2027
Oct 14, 2026
Show all 1 update
  1. Oct 14, 2026
    Not yet recruiting→Recruiting
    1 site added — first site in Sweden
    Show site
    • Swedish School of Sport and Health Sciences · Stockholm, Sweden
    Start date Mar 31, 2026→Aug 15, 2026 (now actual)
    Primary completion Dec 15, 2027→Dec 31, 2027
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07461194
Lead sponsor
The Swedish School of Sport and Health Sciences
Responsible party
Sponsor
First posted
Mar 10, 2026
Start date
Aug 15, 2026
Primary completion
Dec 31, 2027 (estimated)
Completion
Sep 1, 2028 (estimated)
Last update
Oct 14, 2026

Study contacts

Filip J Larsen, PhD
Contact
filip.larsen@gih.se
08-120 53 700

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion